Apartamento en Dubai Healthcare City Phase 2,Affini Tribute Portfolio Residences, 75000 AED - 15867903
el 2 de septiembre de 2026
17
AED75.000
Anual
Affini Tribute Portfolio Residences, Dubai Healthcare City Phase 2, Dubai
Estudio
1 baño
433 ft²

Apartamento en Dubai Healthcare City Phase 2,Affini Tribute Portfolio Residences, 75000 AED - 15867903

Livrichy Real Estate proudly presents this elegant fully furnished studio apartment in Affini Residence, Al Jaddaf—the world's first standalone Tribute Portfolio Residence. Offering hotel-inspired living, premium amenities, and professional management, this residence is ideal for both end users and investors seeking a sophisticated urban lifestyle.

Property Features:

Studio Apartment
1 Bathroom
Fully Furnished
Fully Equipped Kitchen with Appliances
Built-in Wardrobes
Spacious Living & Dining Area
Large Windows with Open Views
1 Covered Parking Space
Premium Interior Finishes

Building Amenities:

Swimming Pool
Fully Equipped Fitness Centre
Residents' Lounge & Co-Working Spaces
Landscaped Gardens
Stylish Lobby
24/7 Concierge & Security
Premium Hospitality Services

Location Highlights:

Walking Distance to Al Jaddaf Metro Station
10 Minutes to Downtown Dubai & Burj Khalifa
10–15 Minutes to Dubai International Airport
Easy Access to Sheikh Zayed Road & Oud Metha Road
Close to Retail, Dining & Lifestyle Destinations

Affini Residence combines branded luxury, exceptional amenities, and a prime location to deliver an elevated lifestyle with the comfort of premium hospitality.

Contact Livrichy Real Estate today for more information or to arrange your private viewing.

Información de la propiedad

  • TipoApartamento
  • FinalidadEn Alquiler
  • N.º de referenciaBayut - LIV-R-AFFINISTU-B-KISH
  • AmuebladoAmueblado
  • TruCheck™ el
    2 de septiembre de 2026
  • Añadido el17 de julio de 2026

Información validada

Validated Check Mark Icon

Información del edificio

Validated Check Mark Icon

Transacciones de propiedades similares

Validated Check Mark Icon

Tendencias e índices

Información regulatoria

Recomendado para ti